CLINICAL_TRIALS
trial_result
· 2013-01-18
Clinical Trial Update: ET 743 (Yondelis) in Men With Advanced Prostate Cancer [Phase 2]
Summary
A Phase 2 trial evaluating ET-743 (Yondelis) in men with advanced prostate cancer has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-01-18